Art

J-GLOBAL ID：202002210324832524   Reference number：20A0740656

Multiple myeloma-associated cardiac amyloidosis in a patient treated with ixazomib.

Ixazomibが奏効している心アミロイドーシス合併多発性骨髄腫

Author (6)： HAYASHI SHIGEKI (川崎医大 血液内科学) ,  SANO FUMINORI (川崎医大 血液内科学) ,  YASUI HARUNOSHIN (川崎医大 血液内科学) ,  HIROSE TADASHI (川崎医大 血液内科学) ,  KONDO EISEI (川崎医大 血液内科学) ,  WADA HIDEHO (川崎医大 血液内科学)
Material： 川崎医学会誌
Volume： 45  Page： 81-87  Publication year： 2019 
JST Material Number： Z0386B  ISSN： 0386-5924  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *Amyloidosis ,...
Semi thesaurus term： M protein ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0740656&from=J-GLOBAL&jstjournalNo=Z0386B") }}

JST classification (4)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of musculoskeletal system  (GG04000A) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Cardiovascular system diseases  (GJ03000C)

Substance index (3)： Ixazomib ,  Dexamethasone ,  CC-5013

Reference (6)：

• Hungria VTM, Crusoé EQ, Bittencourt RI, Maiolino A, Magalhães RJP, Sobrinho JDN, Pinto JV, Fortes RC, Moreira ES, Tanaka PY: New proteasome inhibitors in the treatment of multiple myeloma. Hematol Transfus Cell Ther 41: 76-83, 2019
• Moreau P, Masszi T, Grzasko N, et al.: Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. N Engl J Med 374: 1621-1634, 2016
• Sanchorawala V, Palladini G, Kukreti V, et al.: A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis. Blood 130: 597-605, 2017
• Yamasaki S, Muta T, Higo T, Kusumoto H, Zaitsu E, Miyamoto T, Oda Y, Akashi K: Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis. Hematol Rep 5: e12, 2013 doi: 10.4081/hr.2013.e12.
• Jouni H, Aubry MC, Lacy MQ, Vincent Rajkumar S, Kumar SK, Frye RL, Herrmann J: Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors. Am J Hematol 92: 220-221, 2017

Terms in the title (3)： 心アミロイドーシス ,  合併 ,  多発性骨髄腫